Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01716416
Title Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Washington University School of Medicine

head and neck squamous cell carcinoma


Cetuximab + Pazopanib

Age Groups: adult
Covered Countries USA

No variant requirements are available.